Home/Filings/4/0001209191-21-065173
4//SEC Filing

Suria Hamza 4

Accession 0001209191-21-065173

CIK 0001370053other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 5:20 PM ET

Size

5.5 KB

Accession

0001209191-21-065173

Insider Transaction Report

Form 4
Period: 2021-11-15
Suria Hamza
DirectorPresident, CEO
Transactions
  • Award

    Common Stock

    2021-11-15$22.03/sh+964$21,23768,600 total
Footnotes (2)
  • [F1]Represents shares of Common Stock acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), for the purchase period through November 15, 2021. In accordance with the ESPP, these shares were purchased at 85% of the lesser of the closing price of the Issuer's Common Stock on May 17, 2021 and November 15, 2021.
  • [F2]In addition to the reporting person's common stock directly held as set forth in Table I above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,155,538 shares of common stock, which options vest according to their terms.

Issuer

ANAPTYSBIO, INC

CIK 0001370053

Entity typeother

Related Parties

1
  • filerCIK 0001654495

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 5:20 PM ET
Size
5.5 KB